Role of CABG in the management of obstructive coronary arterial disease in patients with diabetes mellitus
Name
Edelman_Role of CABG.pdf
Size
352.06 KB
Format
Adobe PDF
Checksum (MD5)
4acaad13c34d1b8a7defe031102b61b0
Author(s)
Aronson, Doron
Edelman, Elazer R.
Date Issued
February 2012
Journal
Current Opinion in Pharmacology
Publisher
Elsevier
Citation
Aronson, Doron, and Elazer R Edelman. “Role of CABG in the Management of Obstructive Coronary Arterial Disease in Patients with Diabetes Mellitus.” Current Opinion in Pharmacology 12, no. 2 (April 2012): 134–141.
Version
Author's final manuscript
Abstract
Multiple studies have shown that diabetes mellitus (DM) can affect the efficacy of revascularization therapies and subsequent clinical outcomes. Selection of the appropriate myocardial revascularization strategy is critically important in the setting of multivessel coronary disease. Optimal medical therapy is an appropriate first-line strategy in patients with DM and mild symptoms. When medical therapy does not adequately control symptoms, revascularization with either PCI or CABG may be used. In patients with treated DM, moderate to severe symptoms and complex multivessel coronary disease, coronary artery bypass graft surgery provides better survival, fewer recurrent infarctions and greater freedom from re-intervention. Decisions regarding revascularization in patients with DM must take into account multiple factors and as such require a multidisciplinary team approach (‘heart team’).
MIT Department
Harvard University--MIT Division of Health Sciences and Technology
Terms of Use
Creative Commons Attribution-NonCommercial-NoDerivs License
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1016/j.coph.2012.01.011
